Pharmacokinetic profiles of hydroxysafflor yellow A following intravenous administration of its pure preparations in healthy Chinese volunteers-Reference-Cited by-同舟云学术

Pharmacokinetic profiles of hydroxysafflor yellow A following intravenous administration of its pure preparations in healthy Chinese volunteers

Published:2015-03 Issue: Volume:162 Page:225-230
ISSN:0378-8741
Container-title:Journal of Ethnopharmacology
language:en
Short-container-title:Journal of Ethnopharmacology

Author:

Li Chang-Yin,Yin Jun-Gang,Zhang Jun,Wang Xiao-Xiao,Xu Mei-Juan,Liu Fang,Zou Jian-Dong,Ju Wen-Zheng

Funder

Leading Talents of Scientific Research in TCM of Jiangsu Province

National Science and Technology Major Project

Jiangsu Higher Education Institutions

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference22 articles.

1. Hydroxysafflor yellow A protects against cerebral ischemia-reperfusion injury by anti-apoptotic effect through PI3K/Akt/GSK3beta pathway in rat;Chen;Neurochemical Research,2013

2. European Agency for the Evaluation of Medicinal Products, 2005. Internationnal conference on harmonisation world health organization. Guideline for good clinical practice [emeaweb site]. Ich topic e6 (http://www.emea.eu.int)

3. Exploratory assessment of dose proportionality: review of current approaches and proposal for a practical criterion;Hummel;Pharmaceutical Statistics,2009

4. Hydroxysafflor yellow A induces apoptosis in activated hepatic stellate cells through ERK1/2 pathway in vitro;Li;European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences,2012

5. Clinical pharmacokinetics of tonapofylline: evaluation of dose proportionality, oral bioavailability, and gender and food effects in healthy human subjects;Li;Journal of Clinical Pharmacology,2011

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Supplement to “Effect and Safety of Hydroxysafflor Yellow A for Injection in Patients with Acute Ischemic Stroke of Blood Stasis Syndrome: A Phase II, Multicenter, Randomized, Double-Blind, Multiple-Dose, Active-Controlled Clinical Trial”;Chinese Journal of Integrative Medicine;2024-05-16

2. Chemical composition, pharmacology and pharmacokinetic studies of GuHong injection in the treatment of ischemic stroke;Frontiers in Pharmacology;2023-09-07

3. Protective potential of hydroxysafflor yellow A in cerebral ischemia and reperfusion injury: An overview of evidence from experimental studies;Frontiers in Pharmacology;2022-12-15

4. Preventive effects of a standardized flavonoid extract of safflower in rotenone-induced Parkinson's disease rat model;Neuropharmacology;2022-10

5. Study and exploration of the pharmacokinetics of traditional Tibetan medicine Ruyi Zhenbao tablets after single and long-term administration;Frontiers in Pharmacology;2022-09-29